Vascular Cures Team
Megan Patterson, Chief Executive Officer, has a diverse background in the life sciences which includes roles in regulatory, marketing, business development, and project management. She has been involved primarily in the translational and clinical development stages of biologic, drug, device and diagnostic products. Megan established the U.S. office for Clinical Network Services, an international CRO and consulting firm focused on late pre-clinical and clinical product development, and played a key role in establishing Coté Orphan Consulting, a regulatory affairs firm for orphan products in Washington, DC. She has also been honored with several awards for her work with non-profits and served as an AmeriCorps*VISTA (Volunteer in Service to America) as a community engagement manager in Ferguson, Missouri. Megan has a BS in Chemistry and Biochemistry, Cell & Molecular Biology from Drake University and a Masters in Business Science Keck Graduate Institute of Applied Life Sciences.
Linell Catalan, RN, BSN, Director of Programs & Special Initiatives, is a seasoned healthcare professional seeking to improve health care and wellness for vulnerable populations. She is skilled in chronic illness care coordination and case management. Linell is passionate about improving systems and bridging gaps in health care. She has worked as a health care consultant focused on quality and performance improvement tactics catered to safety-net clinics. More recently, in collaboration with key site stakeholders and the local public health department, she developed a pandemic protocol to minimize workplace exposure and sustain critical operations and production at a biopharmaceutical company. Linell is a Registered Nurse and holds a Bachelor’s of Science in Nursing. She is currently in graduate school, hoping to complete a Masters of Science in Public Health Nursing.
Katelyn Jackson, Director of Operations & Marketing, brings experience in operations management in healthcare, social services and educational settings. Before Vascular Cures, she was Operations Manager at BrightStar Home Care, managing 70 office and nursing staff members. Katelyn also has a personal history with vascular disease and blood clotting disorders. She holds a bachelor’s and master’s degree in the social sciences.
Lisa Huntzinger, Program Manager, oversees Project Voice, an innovative program designed to improve patient outcomes through digital health tools, patient-reported outcomes research and patient empowerment. Before joining Vascular Cures, she held operations and project manager roles for IBM and the Consortium for Service Innovation, a non-profit alliance of organizations focused on innovations in the support industry. She is a graduate of University of California, Berkeley.
David Sayas, Operations Associate, assists the company by performing online marketing and administrative duties. Before Vascular Cures, he was a marketing and social media strategist for Cardinale Automotive Group and Brent Redmond Transportation, managing 40 various marketing accounts for companies all over the U.S. He is currently enrolled at California State University Monterey Bay, and will be receiving his bachelor’s degree in Business Marketing in Fall 2020.
Vascular Cures Volunteers
Tim Robb, collaborator, change agent and consultant brings 40 years of IT and Operations experience to Vascular Cures. Tim’s career spanned several multi-national corporate entities – across a variety of industries – LSI Logic (Semiconductors), Xerox (Imaging), Johnson & Johnson (Medical Devices & Consumer Products) and NetApp (Data Management). Consideration and application of effective Change Management principals were instrumental in setting appropriate user expectations during his career. Tim’s initial engagement with Vascular Cures was on the Project Voice launch at Wake Forest. Tim holds a B.S. in Journalism and an MBA from San Jose State University.
Nipun is currently a Resident in Internal Medicine at NYU who is applying to a Fellowship in Cardiovascular Medicine. He holds a B.A. from Cornell University, an M.P.H from The Dartmouth Institute for Health Policy and Clinical Practice, and a M.D. from the University of Southern California. His research focuses on peripheral vascular disease, specifically how medical comorbidities such as Chronic Kidney Disease and Diabetes impact outcomes following both surgical and endovascular lower extremity revascularization. His work under renowned physician-scientists Dr. Jeffrey Berger and Dr. Nathaniel Smilowitz has been presented at the American Heart Association’s annual conference and published in cardiovascular journals.